Literature DB >> 9572749

Incidence of seroconversion to positivity for hepatitis C antibody in repeat blood donors in England, 1993-5.

K Soldan1, J A Barbara, J Heptonstall.   

Abstract

OBJECTIVE: To estimate the rate of seroconversion to positivity for hepatitis C antibody in repeat blood donors in England and to describe the probable routes of infection in these donors.
DESIGN: Retrospective survey of blood donors becoming positive for hepatitis C antibody and of the results of donation testing.
SETTING: The 14 blood centres in England.
SUBJECTS: All repeat donors giving blood between January 1993 and December 1995. MAIN OUTCOME MEASURES: Number of donors developing hepatitis C between donations during the three years of testing for hepatitis C antibody at English blood centres and the rate of seroconversion among repeat blood donors. Probable routes of infection.
RESULTS: 14 donors during 1993-5 fulfilled the case definition for seroconversion to positivity for hepatitis C antibody. The estimated seroconversion rate for infection with hepatitis C in repeat donors was 0.26 per 100 000 person years (95% confidence interval 0.15 to 0.43). Counselling after diagnosis found that four of these donors had risk factors specified in the criteria excluding people from giving blood but these factors had not come to light before donation. Another of the donors who seroconverted had a risk factor that has since been included in the exclusion criteria. Heterosexual intercourse was considered to be the most likely route of infection for five of the 14 donors.
CONCLUSIONS: The rate of seroconversion for positivity to hepatitis C antibody in repeat blood donors in England was extremely low. During 1993-5 fewer than 1 in 450 000 donations were estimated to have come from repeat donors who had become positive for hepatitis C antibody since the previous donation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9572749      PMCID: PMC28537          DOI: 10.1136/bmj.316.7142.1413

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  14 in total

1.  HCV confirmatory testing of blood donors.

Authors:  M O Gesinde; E M Love; D Lee
Journal:  Lancet       Date:  1992-04-11       Impact factor: 79.321

2.  Reproducibility of hepatitis C virus antibody detection with various confirmatory assays.

Authors:  J P Allain; P E Hewitt; J A Barbara; B C Dow; E A Follett; F Davidson
Journal:  Transfusion       Date:  1997-09       Impact factor: 3.157

3.  Transmission of hepatitis C virus by monoclonal-purified viral-attenuated factor VIII concentrate.

Authors:  C Kessler; J Lusher; G F Pierce; B Pierce; M A Koerper; J C Dickinson
Journal:  Lancet       Date:  1995-11-11       Impact factor: 79.321

4.  Hepatitis C virus transmission by monoclonal purified viral-attenuated factor VIII concentrate.

Authors:  R I Shopnick; D B Brettler; E Bolivar
Journal:  Lancet       Date:  1995-09-02       Impact factor: 79.321

5.  Follow up of blood donors positive for antibodies to hepatitis C virus.

Authors:  K E Ryan; S MacLennan; J A Barbara; P E Hewitt
Journal:  BMJ       Date:  1994-03-12

6.  Hepatitis C virus seroconversion rate in established blood donors.

Authors:  H I Atrah; F Hutchinson; D Gough; F A Ala; M M Ahmed
Journal:  J Med Virol       Date:  1995-08       Impact factor: 2.327

7.  Prevalence and epidemiological characteristics of hepatitis C in Scottish blood donors.

Authors:  R J Crawford; J Gillon; P L Yap; E Brookes; F McOmish; P Simmonds; B C Dow; E A Follett
Journal:  Transfus Med       Date:  1994-06       Impact factor: 2.019

8.  Blood exchanged in ritual ceremonies as a possible route for infection with hepatitis C virus.

Authors:  H I Atrah; F A Ala; D Gough
Journal:  J Clin Pathol       Date:  1994-01       Impact factor: 3.411

9.  Risk factors for hepatitis C virus infection. A case-control study of blood donors in the Trent Region (UK).

Authors:  K R Neal; D A Jones; D Killey; V James
Journal:  Epidemiol Infect       Date:  1994-06       Impact factor: 2.451

10.  Hepatitis C (HCV)-positive blood donors in south-west England: a case control study.

Authors:  M J Goodrick; S F Gray; A M Rouse; A J Waters; N A Anderson
Journal:  Transfus Med       Date:  1994-06       Impact factor: 2.019

View more
  1 in total

Review 1.  Surveillance of transfusion-transmissible infections comparison of systems in five developed countries.

Authors:  Sheila F O'Brien; Shimian Zou; Syria Laperche; Lisa J Brant; Clive R Seed; Steven H Kleinman
Journal:  Transfus Med Rev       Date:  2011-09-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.